Mona Y Alsheikh

Dr. Mona Y Alsheikh

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in World Neurosurgery
Verified
Journal Article
Closed access
YLYu Tung Lo
Yu Tung Lo
MLMichelle Lim-Watson
Michelle Lim-Watson
YSYookyung Seo
Yookyung Seo
NFNoemi Fluetsch
Noemi Fluetsch
MAMoudi M. Alasmari
Moudi M. Alasmari
RMRania A. Mekary
Rania A. Mekary

1 May 2016 in Hospital Pharmacy
Verified
Journal Article
Closed access
MAMona Y Alsheikh
Mona Y Alsheikh
ESEnrique Seoane-Vazquez
Enrique Seoane-Vazquez
BRBrian Rittenhouse
Brian Rittenhouse
EFErin R. Fox
Erin R. Fox
JFJohn Fanikos
John Fanikos
Background: Drug shortages are a problem that has been growing in recent years. This problem has an impact on patient outcomes and public health. Most countries have been affected by a diversity of drug supply chain problems. Objective: To assess explanations for differences in drug shortages reported in the hospital setting in Saudi Arabia (SA) and the United States (US). Methods: Data were collected in May-June 2014 from Brigham and Women's Hospital (BWH) and from 2 Saudi hospitals: King Abdulaziz University Hospital (KAUH) and King Faisal Specialist Hospital and Research Centre (KFSHRC). Drugs were classified using the World Health Organization (WHO) Anatomical Therapeutic Chemical (ATC) classification system. The drug shortages among the hospitals were compared using descriptive statistics and a chi-square test. Results: The percentage of the total number of active ingredients reported in shortage was higher in the US hospital setting (15.1%) than in the Saudi hospitals (10.3%) ( p < .0001). KAUH reported the highest number of shortages ( n = 133), followed by BWH ( n = 42) and KFSHRC ( n = 27). A significantly higher percentage of shortages involved injectable drugs in the US hospital setting (78.1%) than the Saudi hospitals (34.43%) ( p ≤ .0001). Nervous system (17%) and alimentary tract and metabolism agents (15.7%) were the therapeutic areas with the higher number of reported shortages in the US and SA hospital settings, respectively. Conclusions: The number and characteristics of shortages varied by country and hospital. Several factors, including differences in hospital characteristics, number and type of drugs available, and procurement systems, may explain differences in reported shortages.

1 January 2019 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
NLNayan Lamba
Nayan Lamba
NNNadia Noormohamed
Nadia Noormohamed
TSThomas Simjian
Thomas Simjian
MAMona Y Alsheikh
Mona Y Alsheikh
AJAlykhan Jamal
Alykhan Jamal
RMRania A. Mekary
Rania A. Mekary

20 September 2021 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
MAMona Y Alsheikh
Mona Y Alsheikh
MAMaram A. Alzahrani
Maram A. Alzahrani
NANorah A. Alsharif
Norah A. Alsharif
HAHadeel M. Altowairqi
Hadeel M. Altowairqi
SAShahad A. Asiri
Shahad A. Asiri
AAAmal Alotaibi
Amal Alotaibi
Drug shortages continue to pose a significant threat to public health and safety. Drug shortages not only worsen patient outcomes, but also significantly burden healthcare systems with additional costs. This study aimed to assess community pharmacy staff knowledge, opinion, and practice toward drug shortages in Saudi Arabia from November 2019 to March 2020. This was a cross-sectional study carried out among 1,008 community pharmacists from Saudi Arabia using a validated, self-administered and Internet-based survey. Analysis was done using chi square and fisher exact tests. Most participants were males (97.2%), less than 30 years old (48.1%), and non-Saudi citizens (94.4%), and 72.0% had good knowledge of drug shortages (score = 4–5). Around 36.0% reported that it takes 1–3 days to receive a response to the shortage report. There was a statistically significant association between the professional level of the community pharmacists and their opinion about reporting drug shortages (P < .05). Most community pharmacies (56.2%) did not receive any notification about drug shortages. In conclusion, most community pharmacists are knowledgeable and have good practice regarding drug shortages, but their opinions about drug shortages differ according to each pharmacy reporting policy.

27 December 2024 in Medicine
Verified
Journal Article
Open access
MEMahmoud Elhorany
Mahmoud Elhorany
HEHemat El-Sayed El-Horany
Hemat El-Sayed El-Horany
RARania Nagi Abd-Ellatif
Rania Nagi Abd-Ellatif
LDLamees M. Dawood
Lamees M. Dawood
MWMona M. Watany
Mona M. Watany
AAAtef Atef
Atef Atef
Stroke represents a worldwide major cause of death and long-term adult disability. Various human diseases pathogenesis, including stroke, are associated with dysregulation of long noncoding RNA (LncRNA) and microRNA (miR). However, their potential role is yet to be elucidated. This work aimed to assess the role of LncRNA X-inactive specific transcript (XIST), miR-340-5p, and 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase (PFKFB)3 as peripheral blood biomarkers for acute cerebrovascular stroke diagnosis and severity prediction. This cross-sectional study included 120 participants divided into 3 groups; healthy controls, acute ischemic stroke patients, and acute hemorrhagic stroke patients. XIST, miR-340-5p, and PFKFB3 expression were assessed by RT-qPCR, whereas PFKFB3, hypoxia inducible factor 1-alpha (HIF-1α) and vascular endothelial growth factor (VEGF) serum proteins were measured by ELISA. Compared to healthy control, XIST and PFKFB3 mRNA expression were significantly upregulated in stroke patients, with the highest levels in hemorrhagic type, while miR-340-5p expression was significantly downregulated and its lowest level was in hemorrhagic stroke. Serum PFKFB3, HIF-1α, and VEGF levels were significantly elevated in stroke patients with the highest levels in hemorrhagic stroke. These biomarkers correlated with National Institute of Health Stroke Scale (NIHSS). Regression analysis using NIHSS as dependent variable confirmed that PFKFB3 mRNA relative expression was the independent predictor (β = 0.7, P = .003). Receiver operating characteristic analyses revealed that XIST, miR-340-5p, and PFKFB3 mRNA relative expression levels were useful biomarkers discriminating ischemic from hemorrhagic stroke (AUC were 0.99, 0.979, and 0.980, respectively). XIST, miR-340-5p, and PFKFB3 might be involved in acute cerebrovascular stroke pathogenesis and progression providing opportunities for early detection and assessing the severity.

AAAli M Alshahrani
Ali M Alshahrani
MAMona Y Alsheikh
Mona Y Alsheikh
The role of community pharmacists is crucial for promoting health and providing consultation related to sexual and reproductive health. This study measured the perception of community pharmacists in the Kingdom of Saudi Arabia (KSA) towards the provision of counselling services on sex education and reproductive health, including barriers to and proficiency in the delivery of services. A cross-sectional survey was developed and distributed electronically to pharmacists, and responses were analyzed using SPSS version 26. Graphical representations for various opinions on perception, proficiency and barriers were created. More than 80% of pharmacists placed a high value on counselling patients on sex and reproductive health, about 90% counselled their patients very often (74.6%) or often (22.2%), and 3.2% of pharmacists did not counsel patients. Most respondents believed counselling was very important (65.3%) or important (15.1%), with only 19.6% of respondents indicating it was not important. Barriers to offering services included fear from responsibility and liability (M = 4.8), lack of information about patient health (M = 4.7), gender differences (M = 4.7), and lack of social acceptability (M = 4.6). Community pharmacists in KSA possessed positive attitudes, professional education, and willingness to provide counselling to patients on sex education and reproductive health. Apart from the existing barriers that require augmented community pharmacists’ soft skills, clear policies and authorization for offering this type of service are also needed.